{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:45:56Z","timestamp":1758401156931,"version":"3.37.3"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1124\/mol.105.016345","type":"journal-article","created":{"date-parts":[[2006,1,19]],"date-time":"2006-01-19T01:40:12Z","timestamp":1137634812000},"page":"1174-1181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Inhibition of Cardiac Hypertrophy by Triflusal (4-Trifluoromethyl Derivative of Salicylate) and Its Active Metabolite"],"prefix":"10.1016","volume":"69","author":[{"given":"Anna","family":"Planavila","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Rodr\u00edguez-Calvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto Fern\u00e1ndez","family":"de Arriba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa M.","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan C.","family":"Laguna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Merlos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Vazquez-Carrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/mol.105.016345_bib1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0304-3940(00)01202-7","article-title":"Oral administration of the anti-inflammatory substance triflusal results in the downregulation of constitutive transcription factor NF-kappa B in the postnatal rat brain","volume":"288","author":"Acarin","year":"2000","journal-title":"Neurosci Lett"},{"key":"10.1124\/mol.105.016345_bib2","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/sj.bjp.0702441","article-title":"4-Trifluoromethyl derivatives of salicylate, triflusal and its main metabolite 2-hydroxy-4-trifluoromethylbenzoic acid, are potent inhibitors of nuclear factor kappa B activation","volume":"126","author":"Bayon","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.105.016345_bib3","doi-asserted-by":"crossref","first-page":"10100","DOI":"10.1074\/jbc.M110321200","article-title":"Increased reactive oxygen species production down-regulates peroxisome proliferator-activated alpha pathway in C2C12 skeletal muscle cells","volume":"277","author":"Cabrero","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.105.016345_bib4","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.2337\/diabetes.50.8.1883","article-title":"Bezafibrate reduces mRNA levels of adipocyte markers and increases fatty acid oxidation in primary culture of adipocytes","volume":"50","author":"Cabrero","year":"2001","journal-title":"Diabetes"},{"key":"10.1124\/mol.105.016345_bib5","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0026-895X(24)23038-8","article-title":"Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid","volume":"55","author":"de Arriba","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.105.016345_bib6","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/00045391-199609000-00005","article-title":"Pharmacokinetic study of triflusal in elderly subjects after single and repeated oral administration","volume":"3","author":"Ferrari","year":"1996","journal-title":"Am J Ther"},{"key":"10.1124\/mol.105.016345_bib7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/newbio231237a0","article-title":"Indomethacin and aspirin abolish prostaglandin release from spleen","volume":"231","author":"Ferreira","year":"1971","journal-title":"Nat New Biol"},{"key":"10.1124\/mol.105.016345_bib8","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/nature02171","article-title":"The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes","volume":"426","author":"Ganesh","year":"2003","journal-title":"Nature (Lond)"},{"key":"10.1124\/mol.105.016345_bib9","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0008-6363(01)00433-3","article-title":"Reversible activation of nuclear factor-kappa B in human end-stage heart failure after left ventricular mechanical support","volume":"53","author":"Grabellus","year":"2002","journal-title":"Cardiovasc Res"},{"key":"10.1124\/mol.105.016345_bib10","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1126\/science.274.5291.1383","article-title":"Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappa B activation","volume":"274","author":"Grilli","year":"1996","journal-title":"Science (Wash DC)"},{"key":"10.1124\/mol.105.016345_bib11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0076-6879(99)00140-8","article-title":"Inhibition of NF-kappa B activation in vitro and in vivo: role of 26S proteasome","volume":"300","author":"Grisham","year":"1999","journal-title":"Methods Enzymol"},{"key":"10.1124\/mol.105.016345_bib12","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1083\/jcb.200207149","article-title":"Activation of nuclear factor-kappaB is necessary for myotrophin-induced cardiac hypertrophy","volume":"159","author":"Gupta","year":"2002","journal-title":"J Cell Biol"},{"key":"10.1124\/mol.105.016345_bib13","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.bjp.0703820","article-title":"Effect of 4-trifluoromethyl derivatives of salicylate on nuclear factor kappa B-dependent transcription in human astrocytoma cells","volume":"132","author":"Hernandez","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.105.016345_bib14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1006\/jmcc.2001.1505","article-title":"Involvement of reactive oxygen species-mediated NF-kappa B activation in TNF-alpha-induced cardiomyocyte hypertrophy","volume":"34","author":"Higuchi","year":"2002","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/mol.105.016345_bib15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1161\/hc0402.102863","article-title":"Involvement of nuclear factor-kappa B and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy","volume":"105","author":"Hirotani","year":"2002","journal-title":"Circulation"},{"key":"10.1124\/mol.105.016345_bib16","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1056\/NEJM199910213411706","article-title":"Mechanisms of disease\u2014signaling pathways for cardiac hypertrophy and failure","volume":"341","author":"Hunter","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1124\/mol.105.016345_bib17","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0028-3908(03)00204-1","article-title":"Neuroprotective action of flavopiridol, a cyclin-dependent kinase inhibitor, in colchicine-induced apoptosis","volume":"45","author":"Jorda","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1124\/mol.105.016345_bib18","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.immunol.18.1.621","article-title":"Phosphorylation meets ubiquitination: the control of NF-kappa B activity","volume":"18","author":"Karin","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"10.1124\/mol.105.016345_bib19","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1006\/jmcc.1994.1133","article-title":"Thyroid hormone enhances Ca2+ pumping activity of the cardiac sarcoplasmic reticulum by increasing Ca2+ ATPase and decreasing phospholamban expression","volume":"26","author":"Kimura","year":"1994","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/mol.105.016345_bib20","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.8052854","article-title":"Inhibition of NF-kappa-B by sodium-salicylate and aspirin","volume":"265","author":"Kopp","year":"1994","journal-title":"Science (Wash DC)"},{"key":"10.1124\/mol.105.016345_bib21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00042737-200302000-00011","article-title":"Risk of upper gastrointestinal bleeding associated with non-aspirin cardiovascular drugs, analgesics and nonsteroidal anti-inflammatory drugs","volume":"15","author":"Lanas","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1124\/mol.105.016345_bib22","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","article-title":"Prognostic implications of echocardiographically determined left-ventricular mass in the Framingham-Heart-Study","volume":"322","author":"Levy","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1124\/mol.105.016345_bib23","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/01.CIR.102.4.470","article-title":"Left ventricular hypertrophy\u2014pathogenesis, detection and prognosis","volume":"102","author":"Lorell","year":"2000","journal-title":"Circulation"},{"key":"10.1124\/mol.105.016345_bib24","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/01.STR.0000063141.24491.50","article-title":"Comparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction: the TACIP Study: a randomized, double-blind, multicenter trial","volume":"34","author":"Matias-Guiu","year":"2003","journal-title":"Stroke"},{"key":"10.1124\/mol.105.016345_bib25","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2165\/00003495-199855060-00011","article-title":"Triflusal","volume":"55","author":"McNeely","year":"1998","journal-title":"Drugs"},{"key":"10.1124\/mol.105.016345_bib26","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1161\/01.CIR.98.8.794","article-title":"Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-\u03b1 and angiotensin II","volume":"98","author":"Nakamura","year":"1998","journal-title":"Circulation"},{"key":"10.1124\/mol.105.016345_bib27","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1182\/blood.V86.11.4144.bloodjournal86114144","article-title":"Salicylates inhibit lipopolysaccharide-induced transcriptional activation of the tissue factor gene in human monocytic cells","volume":"86","author":"Oeth","year":"1995","journal-title":"Blood"},{"key":"10.1124\/mol.105.016345_bib28","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.4049\/jimmunol.156.10.3961","article-title":"Salicylates inhibit I kappa B-alpha phosphorylation, endothelial-leukocyte adhesion molecule expression and neutrophil transmigration","volume":"156","author":"Pierce","year":"1996","journal-title":"J Immunol"},{"key":"10.1124\/mol.105.016345_bib29","doi-asserted-by":"crossref","first-page":"6668","DOI":"10.1073\/pnas.111155798","article-title":"Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes","volume":"98","author":"Purcell","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.105.016345_bib30","doi-asserted-by":"crossref","first-page":"24847","DOI":"10.1074\/jbc.M910284199","article-title":"Inhibitory and stimulatory effects of lactacystin on expression of nitric oxide synthase type 2 in brain glial cells: the role of I\u03baB-\u03b2","volume":"275","author":"Stasiolek","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.105.016345_bib31","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1128\/MCB.20.6.2269-2284.2000","article-title":"Cytoplasmic sequestration of Rel proteins by I kappa B alpha requires CRM1-dependent nuclear export","volume":"20","author":"Tam","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1124\/mol.105.016345_bib32","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1172\/JCI118095","article-title":"Interleukin-1-beta modulates the growth and phenotype of neonatal rat cardiac myocytes","volume":"96","author":"Thaik","year":"1995","journal-title":"J Clin Investig"},{"key":"10.1124\/mol.105.016345_bib33","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/newbio231232a0","article-title":"Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs","volume":"231","author":"Vane","year":"1971","journal-title":"Nat New Biol"},{"key":"10.1124\/mol.105.016345_bib34","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1161\/01.CIR.98.2.100","article-title":"Induction of cyclooxygenase-2 and activation of nuclear factor-kappa B in myocardium of patients with congestive heart failure","volume":"98","author":"Wong","year":"1998","journal-title":"Circulation"},{"key":"10.1124\/mol.105.016345_bib35","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1161\/hc4001.097186","article-title":"Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes","volume":"104","author":"Yamamoto","year":"2001","journal-title":"Circulation"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24067750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24067750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.105.016345","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T09:05:50Z","timestamp":1740042350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24067750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0026895X24067750"],"URL":"https:\/\/doi.org\/10.1124\/mol.105.016345","relation":{},"ISSN":["0026-895X"],"issn-type":[{"type":"print","value":"0026-895X"}],"subject":[],"published":{"date-parts":[[2006,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of Cardiac Hypertrophy by Triflusal (4-Trifluoromethyl Derivative of Salicylate) and Its Active Metabolite","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.105.016345","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2006 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}